Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: Role of peritoneal dialysis

Peritoneal Dialysis International

Volumn 28, Issue 2, 2008, Pages 113-117

  Chaudhary, Kunal ^a,b   Khanna, Ramesh ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ascites; Cirrhosis; Hemodialysis; Liver disease

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; PERITONEAL DIALYSIS FLUID;

ASCITES; BLEEDING; CATHETER INFECTION; CHRONIC LIVER DISEASE; COMORBIDITY; CREATININE CLEARANCE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; LIVER CIRRHOSIS; MALNUTRITION; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

EID: 42349103271     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800202     Document Type: Review

References (30)

1. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD. Deaths: final data for 2004. In: National Vital Statistics Report. Hyattsville, MD: National Center for Health Statistics; 2006; Vol. 54, No. 19.
2. Ojo AD, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a non renal organ. N Engl J Med 2003; 349:931-40.
3. Tokars JI, Frank, M, Alter M, Arduino MJ. National surveillance of dialysis-associated disease in the United States, 2000. Semin Dial 2002; 15:162-71.
4. Huang CC. Hepatitis in patients with end stage renal disease. J Gastroenterol Hepatol 1997; 12:5236-41.
5. Chan TM, Lok ASF, Cheng IKP. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6:944-7.
6. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41:269-78.
7. Cocchetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit 1983; 5:161-8.
8. Daugherty NA, Hammond KB, Osberg IM. Bilirubin interference with the kinetic Jaffe method for serum creatinine. Clin Chem 1978; 24:392-3.
9. Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin Cin cirrhotic patients. Nephrol Dial Transplant 2006; 21:660-4. Epub 2005 Dec 2.
10. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with renal dysfunction after liver transplantation. Liver Transpl 2005; 11:344-9.
11. Macdonald J, Marcora S, Jibani M, Roberts G, Kumwenda M, Glover R, et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006; 48:712-19.
12. Orlando R, Mussap M, Pleabani M, Oicolli P, De Martin S, FLoreani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48:850-8.
13. Woitas RP, Stofell-Wagner B, Flommersfeld S, Poege U, Scheidermaier P, Klehr HU, et al. Correlation of serum concentration of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000; 46:712-15.
14. Sansoe G, Ferrari A, Castellana CN, Bonardi L, Villa E, Manenti F. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis. Clin Sci (Lond) 2002; 102:91-8.
15. Wilkinson SP, Weston MJ, Parsons V, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8:287-92.
16. Chin-Dusting JP, Rasaratnam B, Jennings GL, Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide induced peripheral vasodilatation seen in cirrhosis. Ann Intern Med 1997; 127:985-8.
17. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339:533-41.
18. Kang ES, Acchiardo SR, Kang AH. Implications for the role of endogenous nitric oxide inhibitors in hemodialysis hypotension. Free Radic Res 2001; 35:341-65.
19. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, et al. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 1995; 123:35-7.
20. Donovan JR Scafer DF, Shaw BW, Sorrell MF. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998; 351:719-21.
21. Winney RJ, Kean DM, Best JJ, Smith MA. Changes in brain water with hemodialysis. Lancet 1986; 2:1107-8.
22. Marcus RG, Messana J, Swartz R. Peritoneal dialysis in endstage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992; 93:35-40.
23. Selgas R, Bajo MA, Jimenez C, Sanchez C, Del Peso G, Cacho G, et al. Peritoneal dialysis in liver disorders. Perit Dial Int 1996; 16(Suppl 1):S215-19.
24. Bajo MA, Selgas R, Jimenez C, Del Peso G, Fernandez-Reyes MJ, Dapena F, et al. CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosis. Adv Perit Dial 1994; 10:73-6.
25. Rubin J, KiLey J, Ray R, McFarland S, Bower J. Continuous ambulatory peritoneal dialysis. Treatment of dialysis-related ascites. Arch Intern Med 1981; 141:1093-5.
26. Gluck Z, Nolph KD. Ascites associated with end stage renal disease. Am J Kidney Dis 1987; 10:9-18.
27. Mactier RA, Dobbie JW, Khanna R. Peritoneal dialysis in fulminant hepatic failure. Perit Dial Bull 1986; 6:199-202.
28. Dadone C, Pincella G, Bonoldi G, Sforzini S, Radaelli B. Transport of water and solutes in uremic patients with chronic hepatic disease in CAPD. Adv Perit Dial 1990; 6:23-5.
29. DeVecchi AF, Colucci P, Salerno F, Scalamonga A, Ponticelli C. Outcome of peritoneal dialysis in chronic renal failure. Am J Kidney Dis 2002; 40:161-8.
30. Durand PY, Freida P, Chanliau J, Gambergoni J, Hestin D, Kessler M. Long term follow up in cirrhotic patients with chronic renal failure undergoing CAPD [Abstract]. Perit Dial Int 1993; 13(Suppl 1):S47.